[Intermediate evaluation of a prospective study of the therapy of malignant non-Hodgkin lymphomas].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009367:Neoplasm Staging; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D011446:Prospective Studies; D011897:Random Allocation; D014750:Vincristine
D000970:Antineoplastic Agents; D002699:Chlorambucil; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D008727:Methotrexate
Zwischenauswertung einer prospektiven Studie zur Therapie der malignen Non-Hodgkin-Lymphome (m-NHL).